Understanding how women in midlife respond to physical activity measurement and its effects on cardiovascular health.
Predictors of Reactivity to Physical Activity Measurement among Women in Midlife with Elevated CVD Risk: Examination Across 7 Studies
This study looks at how women in midlife, especially those at higher risk for heart disease, respond when they know their physical activity is being tracked, and it aims to find ways to encourage more movement in this group while also considering how men react differently.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rowan University NIH-funded |
| Lab location | 1 site (Glassboro, United States) |
| Project ID | NIH-10768082 on NIH RePORTER |
What this research studies
This research investigates how women in midlife, particularly those at elevated risk for cardiovascular disease (CVD), react to being measured for physical activity. By analyzing data from multiple studies, the research aims to identify factors that influence changes in physical activity levels when participants are aware of being monitored. The goal is to better understand these reactions to improve physical activity promotion strategies tailored for this demographic. The study will include both women and men to explore gender differences in these responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 40-60 with elevated cardiovascular disease risk factors such as obesity or hypertension.
Not a fit: Patients who are not in the midlife age range or do not have elevated cardiovascular disease risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for increasing physical activity among women in midlife, ultimately reducing their risk of cardiovascular disease.
How similar studies have performed: Previous research has shown mixed results regarding physical activity measurement reactivity, indicating that this area is still being explored and holds potential for new insights.
Where this research is happening
Glassboro, United States
- Rowan University — Glassboro, United States (Active)
Researchers
- Principal investigator: Arigo, Danielle — Rowan University
- Study coordinator: Arigo, Danielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.